We evaluated the correlations of CELF2 expression with marker levels in specific immune cell subsets, including CD8+ T cells, T cells (general), B cells, monocytes, TAMs, M1 and M2 macrophages, neutrophils, NK cells and DCs in BRCA and LUSC, using LUAD as a control (Table 2 and Figure 4). This evidence concerns the gene CD8A and invasive breast carcinoma.